← Back to Search

Social Work Counseling for Cancer of the Female Reproductive System

N/A

Waitlist Available

Led By Donna S Zhukovsky

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of invasive gynecologic malignancy stages 1-4

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months

Awards & highlights

Study Summary

This trial is testing whether social work counseling can help increase the number of people with gynecologic cancer who have a medical power of attorney, and whether it can affect their attitudes about decision-making.

Who is the study for?

This trial is for new patients at the Gynecologic Oncology Center with stages 1-4 invasive gynecological cancers. Participants must understand and complete medical power of attorney documents, speak English or Spanish, and have a consenting MPOA or primary family caregiver.Check my eligibility

What is being tested?

The study tests if social work counseling and education can increase completion of medical power of attorney documents by patients with gynecological cancer. It also examines how this approach affects their decision-making attitudes and willingness to discuss care preferences.See study design

What are the potential side effects?

Since the interventions involve questionnaire administration and educational videos, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a stage 1-4 gynecologic cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of participants who completed MPOAD after the first educational video

Proportion of participants who completed MPOAD within 3 months after the educational video

Proportion of patients who already have medical power of attorney (MPOAD) at consult

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (questionnaires, educational video)Experimental Treatment2 Interventions

Participants (patients and family caregiver/MPOA) complete questionnaires about knowledge, attitudes, and beliefs of MPOAD. Participants without a MPOAD watch a 4-minute educational video about the importance of the role of MPOA.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,932,933 Total Patients Enrolled

M.D. Anderson Cancer CenterLead Sponsor

2,967 Previous Clinical Trials

1,804,068 Total Patients Enrolled

Donna S ZhukovskyPrincipal InvestigatorM.D. Anderson Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for patients to participate in this trial?

"According to clinicaltrials.gov, this research endeavor is no longer recruiting participants; the trial was initially published on July 17th 2017 and last edited September 22nd 2022. Fortunately, there are 87 alternative studies actively enrolling patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of a Systematic Social Work Driven Approach on Medical Power of Attorney Documentation, Knowledge, Attitudes, and Beliefs in Participants With Stage I-IV Gynecological Cancers

2017. "Impact of a Systematic Social Work Driven Approach on Medical Power of Attorney Documentation, Knowledge, Attitudes, and Beliefs in Participants With Stage I-IV Gynecological Cancers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03037346.

All > Genital Warts